Treace Medical Concepts, Inc. TMCI 5.34 Treace Medical Concepts, Inc.

Home
⇒ 
Stock List ⇒ Treace Medical Concepts, Inc.
Range:3.92-15.98Vol Avg:636040Last Div:0Changes:0.05
Beta:0.21Cap:0.33BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri Apr 23 2021Empoloyees:516
CUSIP:89455T109CIK:0001630627ISIN:US89455T1097Country:US
CEO:Mr. John T. TreaceWebsite:https://www.treace.com
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow